Find Faculty
Ajai Chari, MD
img_Ajai Chari
ADJUNCT PROFESSOR | Medicine, Hematology and Medical Oncology

2013

Health Care Provider of the Year, Leukemia Lymphoma Society

2008

Ewig Teaching Award, Deparatment of Medicine, Columbia University College of Physicians and Surgeons

1994

Phi Beta Kappa, Stanford University

Best Junior Faculty Teacher Award, selected by 2008 Internal Medicine residency class, Columbia University College of Physicians and Surgeons

New York Metro Super Doctors 2011-2015

159
Publications

Selected Publications

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Philippe Moreau, Ajai Chari, Albert Oriol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikander Ailawadhi, Britta Besemer, Javier de la Rubia Comos, Cristina Encinas, Maria Victoria Mateos, Hans Salwender, Paula Rodriguez-Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosiñol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt. Blood Cancer Journal

A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma. Benjamin A. Derman, Ajai Chari, Jeffrey Zonder, Ajay Major, Andrew T. Stefka, Ken Jiang, Theodore Karrison, Jagoda Jasielec, Andrzej Jakubowiak. European Journal of Haematology

Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma. María Victoria Mateos, Ajai Chari, Saad Z. Usmani, Hartmut Goldschmidt, Katja Weisel, Keqin Qi, Anil Londhe, Sandhya Nair, Xiwu Lin, Lixia Pei, Eric Ammann, Rachel Kobos, Jennifer Smit, Trilok Parekh, Alexander Marshall, Mary Slavcev, Philippe Moreau. Clinical Lymphoma, Myeloma and Leukemia

View All Publications

One Gustave L. Levy Place, Box 1185

New York, NY 10029

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Chari during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

  • secura bio
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Pfizer Inc.
  • shattuck labs
  • spargo
  • westchester medical center
  • Epizyme, Inc.
  • Karyopharm Inc.
  • Eisai Inc.
  • MJH
  • AbbVie Inc.
  • International Myeloma Foundation (IMF)
  • Genentech, Inc.
  • Janssen Pharmaceuticals, Inc.
  • WebMD
  • Curio biosciences
  • sciterion
  • Millennium Pharmaceuticals, Inc. (Takeda Pharmaceutical Company Limited )
  • aptitude
  • Clinical Care Options, LLC (CCO)
  • Multiple Myeloma Research Foundation (MMRF)
  • DAVA Oncology, LP

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.